Monday, March 17, 2025 | 04:10 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Strides Pharma Q2 net loss at Rs 87 million on poor operating income

Consolidated revenue also saw a marginal degrowth of 4.6 per cent at Rs 7.3 billion

Strides Pharma Q2 net loss at Rs 87 million on poor operating income
Premium

BS Reporter
Strides Pharma Science posted a consolidated net loss of Rs 87 million for the quarter-ended September 30, on the back of poor operating income and business restructuring. It had reported a net profit of Rs 117 million for the year-ago period. Consolidated revenue also saw a marginal degrowth of 4.6 per cent at Rs 7.3 billion. Regulated markets such as the USA and Australia contributed to 78 per cent of the revenues. It posted a low operating margin of 13.7 per cent as compared to 14.6 per cent in Q1FY18. 

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in